nodes	percent_of_prediction	percent_of_DWPC	metapath
Rocuronium—CHRNA2—epilepsy syndrome	0.331	0.495	CbGaD
Rocuronium—SLCO1A2—epilepsy syndrome	0.219	0.328	CbGaD
Rocuronium—CHRM2—epilepsy syndrome	0.118	0.177	CbGaD
Rocuronium—HTR3A—vagus nerve—epilepsy syndrome	0.00618	0.146	CbGeAlD
Rocuronium—CHRNA1—tongue—epilepsy syndrome	0.00397	0.0937	CbGeAlD
Rocuronium—HTR3A—ganglion—epilepsy syndrome	0.00238	0.0561	CbGeAlD
Rocuronium—SLC22A1—ganglion—epilepsy syndrome	0.00195	0.046	CbGeAlD
Rocuronium—CHRNA2—forebrain—epilepsy syndrome	0.0014	0.033	CbGeAlD
Rocuronium—Vecuronium—CHRNA2—epilepsy syndrome	0.00132	0.203	CrCbGaD
Rocuronium—Pipecuronium—CHRNA2—epilepsy syndrome	0.00124	0.191	CrCbGaD
Rocuronium—Pancuronium—CHRNA2—epilepsy syndrome	0.00112	0.173	CrCbGaD
Rocuronium—HTR3A—brainstem—epilepsy syndrome	0.00104	0.0244	CbGeAlD
Rocuronium—HTR3A—forebrain—epilepsy syndrome	0.000999	0.0236	CbGeAlD
Rocuronium—CHRNA1—head—epilepsy syndrome	0.000965	0.0227	CbGeAlD
Rocuronium—CHRNB1—medulla oblongata—epilepsy syndrome	0.00094	0.0222	CbGeAlD
Rocuronium—HTR3A—telencephalon—epilepsy syndrome	0.000919	0.0217	CbGeAlD
Rocuronium—CHRNB1—midbrain—epilepsy syndrome	0.000859	0.0202	CbGeAlD
Rocuronium—CHRNB1—spinal cord—epilepsy syndrome	0.000838	0.0198	CbGeAlD
Rocuronium—CHRM2—forebrain—epilepsy syndrome	0.000834	0.0197	CbGeAlD
Rocuronium—SLC22A1—forebrain—epilepsy syndrome	0.000819	0.0193	CbGeAlD
Rocuronium—CHRNA2—head—epilepsy syndrome	0.000801	0.0189	CbGeAlD
Rocuronium—SLCO1A2—forebrain—epilepsy syndrome	0.000789	0.0186	CbGeAlD
Rocuronium—CHRM2—telencephalon—epilepsy syndrome	0.000767	0.0181	CbGeAlD
Rocuronium—CHRNA2—nervous system—epilepsy syndrome	0.000759	0.0179	CbGeAlD
Rocuronium—SLC22A1—telencephalon—epilepsy syndrome	0.000753	0.0178	CbGeAlD
Rocuronium—CHRNB1—head—epilepsy syndrome	0.000745	0.0176	CbGeAlD
Rocuronium—CHRNA2—central nervous system—epilepsy syndrome	0.000731	0.0172	CbGeAlD
Rocuronium—SLCO1A2—telencephalon—epilepsy syndrome	0.000725	0.0171	CbGeAlD
Rocuronium—CHRNA2—cerebellum—epilepsy syndrome	0.000714	0.0168	CbGeAlD
Rocuronium—CHRNA1—brain—epilepsy syndrome	0.000699	0.0165	CbGeAlD
Rocuronium—CHRNB1—cerebellum—epilepsy syndrome	0.000665	0.0157	CbGeAlD
Rocuronium—Pipecuronium—CHRM3—epilepsy syndrome	0.00058	0.0897	CrCbGaD
Rocuronium—CHRNA2—brain—epilepsy syndrome	0.00058	0.0137	CbGeAlD
Rocuronium—HTR3A—head—epilepsy syndrome	0.000572	0.0135	CbGeAlD
Rocuronium—SLCO1A2—medulla oblongata—epilepsy syndrome	0.00057	0.0134	CbGeAlD
Rocuronium—Hypotension—Amobarbital—epilepsy syndrome	0.000562	0.00398	CcSEcCtD
Rocuronium—Muscular weakness—Fosphenytoin—epilepsy syndrome	0.00056	0.00396	CcSEcCtD
Rocuronium—Hiccups—Valproic Acid—epilepsy syndrome	0.000558	0.00395	CcSEcCtD
Rocuronium—Asthma—Fosphenytoin—epilepsy syndrome	0.000548	0.00388	CcSEcCtD
Rocuronium—Apnoea—Gabapentin—epilepsy syndrome	0.000545	0.00386	CcSEcCtD
Rocuronium—HTR3A—nervous system—epilepsy syndrome	0.000543	0.0128	CbGeAlD
Rocuronium—CHRNB1—brain—epilepsy syndrome	0.00054	0.0127	CbGeAlD
Rocuronium—Muscular weakness—Diazepam—epilepsy syndrome	0.000537	0.0038	CcSEcCtD
Rocuronium—Asthma—Diazepam—epilepsy syndrome	0.000526	0.00373	CcSEcCtD
Rocuronium—Cardiovascular disorder—Gabapentin—epilepsy syndrome	0.000526	0.00373	CcSEcCtD
Rocuronium—Pancuronium—CHRM3—epilepsy syndrome	0.000525	0.0811	CrCbGaD
Rocuronium—HTR3A—central nervous system—epilepsy syndrome	0.000522	0.0123	CbGeAlD
Rocuronium—SLCO1A2—midbrain—epilepsy syndrome	0.000521	0.0123	CbGeAlD
Rocuronium—Muscular weakness—Felbamate—epilepsy syndrome	0.00052	0.00368	CcSEcCtD
Rocuronium—Respiratory failure—Pregabalin—epilepsy syndrome	0.000513	0.00364	CcSEcCtD
Rocuronium—Asthma—Felbamate—epilepsy syndrome	0.000509	0.00361	CcSEcCtD
Rocuronium—Muscular weakness—Zonisamide—epilepsy syndrome	0.000509	0.0036	CcSEcCtD
Rocuronium—SLCO1A2—spinal cord—epilepsy syndrome	0.000508	0.012	CbGeAlD
Rocuronium—Hiccups—Pregabalin—epilepsy syndrome	0.000504	0.00357	CcSEcCtD
Rocuronium—Muscular weakness—Clonazepam—epilepsy syndrome	0.00049	0.00347	CcSEcCtD
Rocuronium—Muscular weakness—Phenytoin—epilepsy syndrome	0.000487	0.00345	CcSEcCtD
Rocuronium—Muscular weakness—Oxcarbazepine—epilepsy syndrome	0.000484	0.00343	CcSEcCtD
Rocuronium—Asthma—Clonazepam—epilepsy syndrome	0.00048	0.0034	CcSEcCtD
Rocuronium—CHRM2—head—epilepsy syndrome	0.000478	0.0113	CbGeAlD
Rocuronium—Asthma—Phenytoin—epilepsy syndrome	0.000477	0.00338	CcSEcCtD
Rocuronium—Asthma—Oxcarbazepine—epilepsy syndrome	0.000475	0.00336	CcSEcCtD
Rocuronium—Respiratory failure—Gabapentin—epilepsy syndrome	0.000471	0.00333	CcSEcCtD
Rocuronium—SLC22A1—head—epilepsy syndrome	0.000469	0.0111	CbGeAlD
Rocuronium—Bronchospasm—Oxcarbazepine—epilepsy syndrome	0.000467	0.00331	CcSEcCtD
Rocuronium—Muscular weakness—Carbamazepine—epilepsy syndrome	0.000465	0.00329	CcSEcCtD
Rocuronium—Hiccups—Gabapentin—epilepsy syndrome	0.000462	0.00327	CcSEcCtD
Rocuronium—CHRM2—nervous system—epilepsy syndrome	0.000453	0.0107	CbGeAlD
Rocuronium—SLCO1A2—head—epilepsy syndrome	0.000452	0.0106	CbGeAlD
Rocuronium—Muscular weakness—Lamotrigine—epilepsy syndrome	0.000449	0.00318	CcSEcCtD
Rocuronium—SLC22A1—nervous system—epilepsy syndrome	0.000445	0.0105	CbGeAlD
Rocuronium—Shock—Phenobarbital—epilepsy syndrome	0.000444	0.00315	CcSEcCtD
Rocuronium—Hypersensitivity—Amobarbital—epilepsy syndrome	0.000443	0.00314	CcSEcCtD
Rocuronium—Cardiovascular disorder—Topiramate—epilepsy syndrome	0.000443	0.00314	CcSEcCtD
Rocuronium—Pipecuronium—CHRM2—epilepsy syndrome	0.000442	0.0683	CrCbGaD
Rocuronium—Asthma—Lamotrigine—epilepsy syndrome	0.00044	0.00312	CcSEcCtD
Rocuronium—CHRM2—central nervous system—epilepsy syndrome	0.000436	0.0103	CbGeAlD
Rocuronium—Bronchospasm—Lamotrigine—epilepsy syndrome	0.000433	0.00307	CcSEcCtD
Rocuronium—SLCO1A2—nervous system—epilepsy syndrome	0.000428	0.0101	CbGeAlD
Rocuronium—SLC22A1—central nervous system—epilepsy syndrome	0.000428	0.0101	CbGeAlD
Rocuronium—Hypotension—Phenobarbital—epilepsy syndrome	0.000422	0.00299	CcSEcCtD
Rocuronium—Arrhythmia—Propofol—epilepsy syndrome	0.00042	0.00298	CcSEcCtD
Rocuronium—HTR3A—brain—epilepsy syndrome	0.000415	0.00977	CbGeAlD
Rocuronium—SLCO1A2—central nervous system—epilepsy syndrome	0.000412	0.00972	CbGeAlD
Rocuronium—Shock—Lacosamide—epilepsy syndrome	0.000409	0.0029	CcSEcCtD
Rocuronium—SLCO1A2—cerebellum—epilepsy syndrome	0.000403	0.0095	CbGeAlD
Rocuronium—Pancuronium—CHRM2—epilepsy syndrome	0.0004	0.0617	CrCbGaD
Rocuronium—Vomiting—Amobarbital—epilepsy syndrome	0.000383	0.00271	CcSEcCtD
Rocuronium—Rash—Amobarbital—epilepsy syndrome	0.000379	0.00269	CcSEcCtD
Rocuronium—Dermatitis—Amobarbital—epilepsy syndrome	0.000379	0.00268	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Pregabalin—epilepsy syndrome	0.000378	0.00268	CcSEcCtD
Rocuronium—Hypotension—Clobazam—epilepsy syndrome	0.000377	0.00267	CcSEcCtD
Rocuronium—Arrhythmia—Diazepam—epilepsy syndrome	0.000376	0.00267	CcSEcCtD
Rocuronium—Pipecuronium—BCHE—epilepsy syndrome	0.000369	0.0569	CrCbGaD
Rocuronium—Vomiting—Primidone—epilepsy syndrome	0.000369	0.00261	CcSEcCtD
Rocuronium—Rash—Primidone—epilepsy syndrome	0.000365	0.00259	CcSEcCtD
Rocuronium—Dermatitis—Primidone—epilepsy syndrome	0.000365	0.00259	CcSEcCtD
Rocuronium—Pruritus—Trimethadione—epilepsy syndrome	0.000361	0.00256	CcSEcCtD
Rocuronium—Anaphylactic shock—Acetazolamide—epilepsy syndrome	0.00036	0.00255	CcSEcCtD
Rocuronium—Nausea—Amobarbital—epilepsy syndrome	0.000357	0.00253	CcSEcCtD
Rocuronium—Muscular weakness—Valproic Acid—epilepsy syndrome	0.000357	0.00253	CcSEcCtD
Rocuronium—Shock—Acetazolamide—epilepsy syndrome	0.000354	0.00251	CcSEcCtD
Rocuronium—Hypertension—Propofol—epilepsy syndrome	0.000354	0.00251	CcSEcCtD
Rocuronium—CHRM2—brain—epilepsy syndrome	0.000346	0.00816	CbGeAlD
Rocuronium—Nausea—Primidone—epilepsy syndrome	0.000344	0.00244	CcSEcCtD
Rocuronium—SLC22A1—brain—epilepsy syndrome	0.00034	0.00801	CbGeAlD
Rocuronium—Arrhythmia—Oxcarbazepine—epilepsy syndrome	0.000339	0.0024	CcSEcCtD
Rocuronium—Anaphylactic shock—Propofol—epilepsy syndrome	0.000334	0.00237	CcSEcCtD
Rocuronium—Pancuronium—BCHE—epilepsy syndrome	0.000333	0.0515	CrCbGaD
Rocuronium—Hypersensitivity—Phenobarbital—epilepsy syndrome	0.000333	0.00236	CcSEcCtD
Rocuronium—Hypertension—Fosphenytoin—epilepsy syndrome	0.00033	0.00234	CcSEcCtD
Rocuronium—Shock—Propofol—epilepsy syndrome	0.000329	0.00233	CcSEcCtD
Rocuronium—SLCO1A2—brain—epilepsy syndrome	0.000327	0.00771	CbGeAlD
Rocuronium—Anaphylactic shock—Midazolam—epilepsy syndrome	0.000327	0.00232	CcSEcCtD
Rocuronium—Hypersensitivity—Rufinamide—epilepsy syndrome	0.000327	0.00231	CcSEcCtD
Rocuronium—Tachycardia—Propofol—epilepsy syndrome	0.000326	0.00231	CcSEcCtD
Rocuronium—Arrhythmia—Carbamazepine—epilepsy syndrome	0.000326	0.00231	CcSEcCtD
Rocuronium—Vomiting—Trimethadione—epilepsy syndrome	0.000324	0.0023	CcSEcCtD
Rocuronium—Muscular weakness—Pregabalin—epilepsy syndrome	0.000323	0.00229	CcSEcCtD
Rocuronium—Shock—Midazolam—epilepsy syndrome	0.000322	0.00228	CcSEcCtD
Rocuronium—Rash—Trimethadione—epilepsy syndrome	0.000322	0.00228	CcSEcCtD
Rocuronium—Dermatitis—Trimethadione—epilepsy syndrome	0.000321	0.00228	CcSEcCtD
Rocuronium—Tachycardia—Midazolam—epilepsy syndrome	0.000319	0.00226	CcSEcCtD
Rocuronium—Asthma—Pregabalin—epilepsy syndrome	0.000316	0.00224	CcSEcCtD
Rocuronium—Pruritus—Rufinamide—epilepsy syndrome	0.000314	0.00222	CcSEcCtD
Rocuronium—Hypotension—Propofol—epilepsy syndrome	0.000312	0.00221	CcSEcCtD
Rocuronium—Anaphylactic shock—Fosphenytoin—epilepsy syndrome	0.000312	0.00221	CcSEcCtD
Rocuronium—Shock—Fosphenytoin—epilepsy syndrome	0.000307	0.00217	CcSEcCtD
Rocuronium—Hypersensitivity—Lacosamide—epilepsy syndrome	0.000307	0.00217	CcSEcCtD
Rocuronium—Hypertension—Felbamate—epilepsy syndrome	0.000306	0.00217	CcSEcCtD
Rocuronium—Hypotension—Midazolam—epilepsy syndrome	0.000306	0.00217	CcSEcCtD
Rocuronium—Tachycardia—Fosphenytoin—epilepsy syndrome	0.000304	0.00216	CcSEcCtD
Rocuronium—Nausea—Trimethadione—epilepsy syndrome	0.000303	0.00215	CcSEcCtD
Rocuronium—Hypertension—Zonisamide—epilepsy syndrome	0.0003	0.00212	CcSEcCtD
Rocuronium—Anaphylactic shock—Diazepam—epilepsy syndrome	0.000299	0.00212	CcSEcCtD
Rocuronium—Muscular weakness—Gabapentin—epilepsy syndrome	0.000296	0.0021	CcSEcCtD
Rocuronium—Pruritus—Lacosamide—epilepsy syndrome	0.000294	0.00209	CcSEcCtD
Rocuronium—Shock—Diazepam—epilepsy syndrome	0.000294	0.00209	CcSEcCtD
Rocuronium—Tachycardia—Diazepam—epilepsy syndrome	0.000292	0.00207	CcSEcCtD
Rocuronium—Hypotension—Fosphenytoin—epilepsy syndrome	0.000291	0.00206	CcSEcCtD
Rocuronium—Asthma—Gabapentin—epilepsy syndrome	0.00029	0.00205	CcSEcCtD
Rocuronium—Anaphylactic shock—Felbamate—epilepsy syndrome	0.00029	0.00205	CcSEcCtD
Rocuronium—Vomiting—Phenobarbital—epilepsy syndrome	0.000287	0.00203	CcSEcCtD
Rocuronium—Hypertension—Phenytoin—epilepsy syndrome	0.000287	0.00203	CcSEcCtD
Rocuronium—Pruritus—Clobazam—epilepsy syndrome	0.000286	0.00202	CcSEcCtD
Rocuronium—Hypertension—Oxcarbazepine—epilepsy syndrome	0.000286	0.00202	CcSEcCtD
Rocuronium—Bronchospasm—Gabapentin—epilepsy syndrome	0.000285	0.00202	CcSEcCtD
Rocuronium—Rash—Phenobarbital—epilepsy syndrome	0.000285	0.00202	CcSEcCtD
Rocuronium—Dermatitis—Phenobarbital—epilepsy syndrome	0.000284	0.00201	CcSEcCtD
Rocuronium—Tachycardia—Felbamate—epilepsy syndrome	0.000283	0.002	CcSEcCtD
Rocuronium—Vomiting—Rufinamide—epilepsy syndrome	0.000282	0.002	CcSEcCtD
Rocuronium—Hypotension—Diazepam—epilepsy syndrome	0.00028	0.00198	CcSEcCtD
Rocuronium—Rash—Rufinamide—epilepsy syndrome	0.000279	0.00198	CcSEcCtD
Rocuronium—Dermatitis—Rufinamide—epilepsy syndrome	0.000279	0.00198	CcSEcCtD
Rocuronium—Shock—Zonisamide—epilepsy syndrome	0.000279	0.00198	CcSEcCtD
Rocuronium—Tachycardia—Zonisamide—epilepsy syndrome	0.000277	0.00196	CcSEcCtD
Rocuronium—Hypertension—Carbamazepine—epilepsy syndrome	0.000274	0.00194	CcSEcCtD
Rocuronium—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.000273	0.00194	CcSEcCtD
Rocuronium—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.000271	0.00192	CcSEcCtD
Rocuronium—Hypotension—Felbamate—epilepsy syndrome	0.000271	0.00192	CcSEcCtD
Rocuronium—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.00027	0.00191	CcSEcCtD
Rocuronium—Nausea—Phenobarbital—epilepsy syndrome	0.000268	0.0019	CcSEcCtD
Rocuronium—Shock—Phenytoin—epilepsy syndrome	0.000267	0.00189	CcSEcCtD
Rocuronium—Tachycardia—Clonazepam—epilepsy syndrome	0.000267	0.00189	CcSEcCtD
Rocuronium—Shock—Oxcarbazepine—epilepsy syndrome	0.000266	0.00188	CcSEcCtD
Rocuronium—Hypotension—Zonisamide—epilepsy syndrome	0.000265	0.00188	CcSEcCtD
Rocuronium—Tachycardia—Phenytoin—epilepsy syndrome	0.000265	0.00188	CcSEcCtD
Rocuronium—Hypertension—Lamotrigine—epilepsy syndrome	0.000265	0.00188	CcSEcCtD
Rocuronium—Vomiting—Lacosamide—epilepsy syndrome	0.000265	0.00187	CcSEcCtD
Rocuronium—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000263	0.00187	CcSEcCtD
Rocuronium—Nausea—Rufinamide—epilepsy syndrome	0.000263	0.00186	CcSEcCtD
Rocuronium—Rash—Lacosamide—epilepsy syndrome	0.000262	0.00186	CcSEcCtD
Rocuronium—Dermatitis—Lacosamide—epilepsy syndrome	0.000262	0.00186	CcSEcCtD
Rocuronium—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.000259	0.00183	CcSEcCtD
Rocuronium—Vomiting—Clobazam—epilepsy syndrome	0.000257	0.00182	CcSEcCtD
Rocuronium—Hypotension—Clonazepam—epilepsy syndrome	0.000255	0.00181	CcSEcCtD
Rocuronium—Shock—Carbamazepine—epilepsy syndrome	0.000255	0.00181	CcSEcCtD
Rocuronium—Rash—Clobazam—epilepsy syndrome	0.000255	0.0018	CcSEcCtD
Rocuronium—Dermatitis—Clobazam—epilepsy syndrome	0.000254	0.0018	CcSEcCtD
Rocuronium—Hypotension—Phenytoin—epilepsy syndrome	0.000254	0.0018	CcSEcCtD
Rocuronium—Tachycardia—Carbamazepine—epilepsy syndrome	0.000253	0.00179	CcSEcCtD
Rocuronium—Hypotension—Oxcarbazepine—epilepsy syndrome	0.000252	0.00179	CcSEcCtD
Rocuronium—Arrhythmia—Valproic Acid—epilepsy syndrome	0.00025	0.00177	CcSEcCtD
Rocuronium—Muscular weakness—Topiramate—epilepsy syndrome	0.000249	0.00176	CcSEcCtD
Rocuronium—Nausea—Lacosamide—epilepsy syndrome	0.000247	0.00175	CcSEcCtD
Rocuronium—Shock—Lamotrigine—epilepsy syndrome	0.000246	0.00174	CcSEcCtD
Rocuronium—Tachycardia—Lamotrigine—epilepsy syndrome	0.000244	0.00173	CcSEcCtD
Rocuronium—Asthma—Topiramate—epilepsy syndrome	0.000244	0.00173	CcSEcCtD
Rocuronium—Hypotension—Carbamazepine—epilepsy syndrome	0.000242	0.00171	CcSEcCtD
Rocuronium—Hypersensitivity—Midazolam—epilepsy syndrome	0.000241	0.00171	CcSEcCtD
Rocuronium—Nausea—Clobazam—epilepsy syndrome	0.00024	0.0017	CcSEcCtD
Rocuronium—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000238	0.00169	CcSEcCtD
Rocuronium—Pruritus—Propofol—epilepsy syndrome	0.000237	0.00168	CcSEcCtD
Rocuronium—Pruritus—Midazolam—epilepsy syndrome	0.000231	0.00164	CcSEcCtD
Rocuronium—Vomiting—Acetazolamide—epilepsy syndrome	0.000229	0.00162	CcSEcCtD
Rocuronium—Pruritus—Levetiracetam—epilepsy syndrome	0.000229	0.00162	CcSEcCtD
Rocuronium—Arrhythmia—Pregabalin—epilepsy syndrome	0.000226	0.0016	CcSEcCtD
Rocuronium—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000224	0.00159	CcSEcCtD
Rocuronium—Pruritus—Fosphenytoin—epilepsy syndrome	0.000221	0.00156	CcSEcCtD
Rocuronium—Hypersensitivity—Diazepam—epilepsy syndrome	0.00022	0.00156	CcSEcCtD
Rocuronium—Pruritus—Vigabatrin—epilepsy syndrome	0.000215	0.00152	CcSEcCtD
Rocuronium—Nausea—Acetazolamide—epilepsy syndrome	0.000214	0.00151	CcSEcCtD
Rocuronium—Vomiting—Propofol—epilepsy syndrome	0.000213	0.00151	CcSEcCtD
Rocuronium—Pruritus—Diazepam—epilepsy syndrome	0.000212	0.0015	CcSEcCtD
Rocuronium—Rash—Propofol—epilepsy syndrome	0.000211	0.00149	CcSEcCtD
Rocuronium—Dermatitis—Propofol—epilepsy syndrome	0.000211	0.00149	CcSEcCtD
Rocuronium—Hypertension—Valproic Acid—epilepsy syndrome	0.00021	0.00149	CcSEcCtD
Rocuronium—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000209	0.00148	CcSEcCtD
Rocuronium—Vomiting—Midazolam—epilepsy syndrome	0.000208	0.00147	CcSEcCtD
Rocuronium—Rash—Midazolam—epilepsy syndrome	0.000206	0.00146	CcSEcCtD
Rocuronium—Dermatitis—Midazolam—epilepsy syndrome	0.000206	0.00146	CcSEcCtD
Rocuronium—Vomiting—Levetiracetam—epilepsy syndrome	0.000205	0.00146	CcSEcCtD
Rocuronium—Pruritus—Felbamate—epilepsy syndrome	0.000205	0.00145	CcSEcCtD
Rocuronium—Rash—Levetiracetam—epilepsy syndrome	0.000204	0.00144	CcSEcCtD
Rocuronium—Dermatitis—Levetiracetam—epilepsy syndrome	0.000204	0.00144	CcSEcCtD
Rocuronium—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000201	0.00143	CcSEcCtD
Rocuronium—Pruritus—Zonisamide—epilepsy syndrome	0.000201	0.00142	CcSEcCtD
Rocuronium—Hypersensitivity—Phenytoin—epilepsy syndrome	0.0002	0.00142	CcSEcCtD
Rocuronium—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000199	0.00141	CcSEcCtD
Rocuronium—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000199	0.00141	CcSEcCtD
Rocuronium—Nausea—Propofol—epilepsy syndrome	0.000199	0.00141	CcSEcCtD
Rocuronium—Vomiting—Fosphenytoin—epilepsy syndrome	0.000198	0.0014	CcSEcCtD
Rocuronium—Rash—Fosphenytoin—epilepsy syndrome	0.000197	0.00139	CcSEcCtD
Rocuronium—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000196	0.00139	CcSEcCtD
Rocuronium—Nausea—Midazolam—epilepsy syndrome	0.000194	0.00138	CcSEcCtD
Rocuronium—Tachycardia—Valproic Acid—epilepsy syndrome	0.000194	0.00138	CcSEcCtD
Rocuronium—Pruritus—Clonazepam—epilepsy syndrome	0.000193	0.00137	CcSEcCtD
Rocuronium—Vomiting—Vigabatrin—epilepsy syndrome	0.000193	0.00137	CcSEcCtD
Rocuronium—Pruritus—Phenytoin—epilepsy syndrome	0.000192	0.00136	CcSEcCtD
Rocuronium—Nausea—Levetiracetam—epilepsy syndrome	0.000192	0.00136	CcSEcCtD
Rocuronium—Rash—Vigabatrin—epilepsy syndrome	0.000192	0.00136	CcSEcCtD
Rocuronium—Dermatitis—Vigabatrin—epilepsy syndrome	0.000191	0.00136	CcSEcCtD
Rocuronium—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000191	0.00135	CcSEcCtD
Rocuronium—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000191	0.00135	CcSEcCtD
Rocuronium—Hypertension—Pregabalin—epilepsy syndrome	0.00019	0.00135	CcSEcCtD
Rocuronium—Vomiting—Diazepam—epilepsy syndrome	0.00019	0.00135	CcSEcCtD
Rocuronium—Rash—Diazepam—epilepsy syndrome	0.000189	0.00134	CcSEcCtD
Rocuronium—Dermatitis—Diazepam—epilepsy syndrome	0.000189	0.00134	CcSEcCtD
Rocuronium—Hypotension—Valproic Acid—epilepsy syndrome	0.000186	0.00132	CcSEcCtD
Rocuronium—Nausea—Fosphenytoin—epilepsy syndrome	0.000185	0.00131	CcSEcCtD
Rocuronium—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000184	0.00131	CcSEcCtD
Rocuronium—Vomiting—Felbamate—epilepsy syndrome	0.000184	0.0013	CcSEcCtD
Rocuronium—Pruritus—Carbamazepine—epilepsy syndrome	0.000183	0.0013	CcSEcCtD
Rocuronium—Rash—Felbamate—epilepsy syndrome	0.000183	0.00129	CcSEcCtD
Rocuronium—Dermatitis—Felbamate—epilepsy syndrome	0.000182	0.00129	CcSEcCtD
Rocuronium—Nausea—Vigabatrin—epilepsy syndrome	0.000181	0.00128	CcSEcCtD
Rocuronium—Vomiting—Zonisamide—epilepsy syndrome	0.00018	0.00128	CcSEcCtD
Rocuronium—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.00018	0.00127	CcSEcCtD
Rocuronium—Rash—Zonisamide—epilepsy syndrome	0.000179	0.00127	CcSEcCtD
Rocuronium—Dermatitis—Zonisamide—epilepsy syndrome	0.000179	0.00126	CcSEcCtD
Rocuronium—Nausea—Diazepam—epilepsy syndrome	0.000178	0.00126	CcSEcCtD
Rocuronium—Pruritus—Lamotrigine—epilepsy syndrome	0.000177	0.00125	CcSEcCtD
Rocuronium—Shock—Pregabalin—epilepsy syndrome	0.000177	0.00125	CcSEcCtD
Rocuronium—Tachycardia—Pregabalin—epilepsy syndrome	0.000176	0.00124	CcSEcCtD
Rocuronium—Hypertension—Gabapentin—epilepsy syndrome	0.000174	0.00124	CcSEcCtD
Rocuronium—Vomiting—Clonazepam—epilepsy syndrome	0.000174	0.00123	CcSEcCtD
Rocuronium—Vomiting—Phenytoin—epilepsy syndrome	0.000173	0.00122	CcSEcCtD
Rocuronium—Rash—Clonazepam—epilepsy syndrome	0.000172	0.00122	CcSEcCtD
Rocuronium—Dermatitis—Clonazepam—epilepsy syndrome	0.000172	0.00122	CcSEcCtD
Rocuronium—Nausea—Felbamate—epilepsy syndrome	0.000172	0.00122	CcSEcCtD
Rocuronium—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000172	0.00122	CcSEcCtD
Rocuronium—Rash—Phenytoin—epilepsy syndrome	0.000171	0.00121	CcSEcCtD
Rocuronium—Dermatitis—Phenytoin—epilepsy syndrome	0.000171	0.00121	CcSEcCtD
Rocuronium—Rash—Oxcarbazepine—epilepsy syndrome	0.00017	0.00121	CcSEcCtD
Rocuronium—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.00017	0.0012	CcSEcCtD
Rocuronium—Nausea—Zonisamide—epilepsy syndrome	0.000168	0.00119	CcSEcCtD
Rocuronium—Hypotension—Pregabalin—epilepsy syndrome	0.000168	0.00119	CcSEcCtD
Rocuronium—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000165	0.00117	CcSEcCtD
Rocuronium—Vomiting—Carbamazepine—epilepsy syndrome	0.000165	0.00117	CcSEcCtD
Rocuronium—Rash—Carbamazepine—epilepsy syndrome	0.000163	0.00116	CcSEcCtD
Rocuronium—Dermatitis—Carbamazepine—epilepsy syndrome	0.000163	0.00116	CcSEcCtD
Rocuronium—Nausea—Clonazepam—epilepsy syndrome	0.000162	0.00115	CcSEcCtD
Rocuronium—Shock—Gabapentin—epilepsy syndrome	0.000162	0.00115	CcSEcCtD
Rocuronium—Nausea—Phenytoin—epilepsy syndrome	0.000161	0.00114	CcSEcCtD
Rocuronium—Tachycardia—Gabapentin—epilepsy syndrome	0.000161	0.00114	CcSEcCtD
Rocuronium—Nausea—Oxcarbazepine—epilepsy syndrome	0.00016	0.00114	CcSEcCtD
Rocuronium—Vomiting—Lamotrigine—epilepsy syndrome	0.000159	0.00113	CcSEcCtD
Rocuronium—Rash—Lamotrigine—epilepsy syndrome	0.000158	0.00112	CcSEcCtD
Rocuronium—Dermatitis—Lamotrigine—epilepsy syndrome	0.000158	0.00112	CcSEcCtD
Rocuronium—Hypotension—Gabapentin—epilepsy syndrome	0.000154	0.00109	CcSEcCtD
Rocuronium—Nausea—Carbamazepine—epilepsy syndrome	0.000154	0.00109	CcSEcCtD
Rocuronium—Vecuronium—ABCB1—epilepsy syndrome	0.000154	0.0237	CrCbGaD
Rocuronium—Nausea—Lamotrigine—epilepsy syndrome	0.000149	0.00105	CcSEcCtD
Rocuronium—Hypertension—Topiramate—epilepsy syndrome	0.000147	0.00104	CcSEcCtD
Rocuronium—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000147	0.00104	CcSEcCtD
Rocuronium—Pruritus—Valproic Acid—epilepsy syndrome	0.000141	0.000997	CcSEcCtD
Rocuronium—Shock—Topiramate—epilepsy syndrome	0.000137	0.000967	CcSEcCtD
Rocuronium—Tachycardia—Topiramate—epilepsy syndrome	0.000135	0.000959	CcSEcCtD
Rocuronium—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000133	0.000939	CcSEcCtD
Rocuronium—Hypotension—Topiramate—epilepsy syndrome	0.00013	0.000918	CcSEcCtD
Rocuronium—Pruritus—Pregabalin—epilepsy syndrome	0.000127	0.000901	CcSEcCtD
Rocuronium—Vomiting—Valproic Acid—epilepsy syndrome	0.000126	0.000896	CcSEcCtD
Rocuronium—Rash—Valproic Acid—epilepsy syndrome	0.000125	0.000889	CcSEcCtD
Rocuronium—Dermatitis—Valproic Acid—epilepsy syndrome	0.000125	0.000888	CcSEcCtD
Rocuronium—SLC22A1—Midazolam—epilepsy syndrome	0.000125	1	CbGbCtD
Rocuronium—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000122	0.000861	CcSEcCtD
Rocuronium—Nausea—Valproic Acid—epilepsy syndrome	0.000118	0.000837	CcSEcCtD
Rocuronium—Pruritus—Gabapentin—epilepsy syndrome	0.000117	0.000827	CcSEcCtD
Rocuronium—Vomiting—Pregabalin—epilepsy syndrome	0.000114	0.00081	CcSEcCtD
Rocuronium—Rash—Pregabalin—epilepsy syndrome	0.000113	0.000803	CcSEcCtD
Rocuronium—Dermatitis—Pregabalin—epilepsy syndrome	0.000113	0.000803	CcSEcCtD
Rocuronium—Nausea—Pregabalin—epilepsy syndrome	0.000107	0.000757	CcSEcCtD
Rocuronium—Vomiting—Gabapentin—epilepsy syndrome	0.000105	0.000743	CcSEcCtD
Rocuronium—Rash—Gabapentin—epilepsy syndrome	0.000104	0.000737	CcSEcCtD
Rocuronium—Dermatitis—Gabapentin—epilepsy syndrome	0.000104	0.000736	CcSEcCtD
Rocuronium—Hypersensitivity—Topiramate—epilepsy syndrome	0.000102	0.000724	CcSEcCtD
Rocuronium—Pruritus—Topiramate—epilepsy syndrome	9.82e-05	0.000695	CcSEcCtD
Rocuronium—Nausea—Gabapentin—epilepsy syndrome	9.8e-05	0.000694	CcSEcCtD
Rocuronium—Vomiting—Topiramate—epilepsy syndrome	8.82e-05	0.000625	CcSEcCtD
Rocuronium—Rash—Topiramate—epilepsy syndrome	8.75e-05	0.00062	CcSEcCtD
Rocuronium—Dermatitis—Topiramate—epilepsy syndrome	8.74e-05	0.000619	CcSEcCtD
Rocuronium—Nausea—Topiramate—epilepsy syndrome	8.24e-05	0.000584	CcSEcCtD
Rocuronium—CHRM2—GPCR downstream signaling—CHRM1—epilepsy syndrome	1.4e-05	9.92e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—GRM1—epilepsy syndrome	1.4e-05	9.92e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GRM8—epilepsy syndrome	1.39e-05	9.85e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—PRKCB—epilepsy syndrome	1.39e-05	9.84e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—AQP1—epilepsy syndrome	1.38e-05	9.79e-05	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	1.37e-05	9.69e-05	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	1.37e-05	9.67e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.36e-05	9.62e-05	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	1.35e-05	9.57e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ACKR4—epilepsy syndrome	1.35e-05	9.52e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ASAH1—epilepsy syndrome	1.33e-05	9.43e-05	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—POMC—epilepsy syndrome	1.33e-05	9.41e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.33e-05	9.4e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—OPRD1—epilepsy syndrome	1.33e-05	9.39e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GNAO1—epilepsy syndrome	1.33e-05	9.39e-05	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	1.33e-05	9.39e-05	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	1.32e-05	9.36e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.32e-05	9.33e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—GAL—epilepsy syndrome	1.32e-05	9.32e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CHRM3—epilepsy syndrome	1.3e-05	9.22e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—GRM5—epilepsy syndrome	1.3e-05	9.22e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—STXBP1—epilepsy syndrome	1.3e-05	9.18e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CHRM1—epilepsy syndrome	1.27e-05	9.01e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CCR7—epilepsy syndrome	1.27e-05	9.01e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PDYN—epilepsy syndrome	1.27e-05	9.01e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GRM1—epilepsy syndrome	1.27e-05	9.01e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ALAD—epilepsy syndrome	1.26e-05	8.94e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NT5E—epilepsy syndrome	1.26e-05	8.94e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.26e-05	8.9e-05	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	1.26e-05	8.89e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CHRM3—epilepsy syndrome	1.25e-05	8.85e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—KCNJ11—epilepsy syndrome	1.25e-05	8.85e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—BDKRB1—epilepsy syndrome	1.23e-05	8.67e-05	CbGpPWpGaD
Rocuronium—SLC22A1—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	1.22e-05	8.65e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SSTR4—epilepsy syndrome	1.22e-05	8.61e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SSTR5—epilepsy syndrome	1.22e-05	8.61e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—AVP—epilepsy syndrome	1.21e-05	8.57e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CACNA1A—epilepsy syndrome	1.21e-05	8.53e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ALDH7A1—epilepsy syndrome	1.21e-05	8.53e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GAL—epilepsy syndrome	1.2e-05	8.47e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—GABBR1—epilepsy syndrome	1.19e-05	8.43e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GRM5—epilepsy syndrome	1.18e-05	8.37e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CHRM3—epilepsy syndrome	1.18e-05	8.37e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ST3GAL3—epilepsy syndrome	1.18e-05	8.35e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCR10—epilepsy syndrome	1.17e-05	8.26e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.17e-05	8.24e-05	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	1.16e-05	8.2e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ADSL—epilepsy syndrome	1.16e-05	8.18e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—HRH3—epilepsy syndrome	1.14e-05	8.08e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.14e-05	8.08e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CX3CR1—epilepsy syndrome	1.14e-05	8.03e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GLUL—epilepsy syndrome	1.13e-05	8.02e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—OPRM1—epilepsy syndrome	1.13e-05	7.96e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CACNA1D—epilepsy syndrome	1.11e-05	7.87e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—BDKRB1—epilepsy syndrome	1.11e-05	7.87e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CX3CL1—epilepsy syndrome	1.11e-05	7.87e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GABBR1—epilepsy syndrome	1.08e-05	7.66e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CCR3—epilepsy syndrome	1.06e-05	7.52e-05	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	1.06e-05	7.48e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—TXNRD1—epilepsy syndrome	1.04e-05	7.37e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—HRH3—epilepsy syndrome	1.04e-05	7.34e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—NPY—epilepsy syndrome	1.04e-05	7.32e-05	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	1.03e-05	7.32e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.03e-05	7.32e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—CCR5—epilepsy syndrome	1.03e-05	7.29e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.03e-05	7.25e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—OPRM1—epilepsy syndrome	1.02e-05	7.23e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ABCG2—epilepsy syndrome	1.02e-05	7.22e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GRM2—epilepsy syndrome	1.02e-05	7.22e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—AQP1—epilepsy syndrome	1.01e-05	7.15e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—HTR2A—epilepsy syndrome	1.01e-05	7.13e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CXCL2—epilepsy syndrome	9.99e-06	7.07e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CRH—epilepsy syndrome	9.99e-06	7.07e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—OXT—epilepsy syndrome	9.99e-06	7.07e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP2C19—epilepsy syndrome	9.95e-06	7.03e-05	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	9.94e-06	7.03e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	9.93e-06	7.02e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP11A1—epilepsy syndrome	9.88e-06	6.99e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.81e-06	6.94e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CCR3—epilepsy syndrome	9.65e-06	6.83e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—AGT—epilepsy syndrome	9.57e-06	6.77e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—NPY—epilepsy syndrome	9.41e-06	6.65e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SSTR3—epilepsy syndrome	9.23e-06	6.53e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CHRM3—epilepsy syndrome	9.14e-06	6.47e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—KCNJ11—epilepsy syndrome	9.14e-06	6.47e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CXCL2—epilepsy syndrome	9.07e-06	6.42e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CCL3—epilepsy syndrome	9.07e-06	6.42e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—OXT—epilepsy syndrome	9.07e-06	6.42e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CRH—epilepsy syndrome	9.07e-06	6.42e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CCR2—epilepsy syndrome	9.04e-06	6.39e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—SST—epilepsy syndrome	9.04e-06	6.39e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ST3GAL3—epilepsy syndrome	9.03e-06	6.39e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.95e-06	6.33e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP2D6—epilepsy syndrome	8.92e-06	6.31e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCR9—epilepsy syndrome	8.85e-06	6.26e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ARHGEF9—epilepsy syndrome	8.85e-06	6.26e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SSTR1—epilepsy syndrome	8.85e-06	6.26e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCR8—epilepsy syndrome	8.85e-06	6.26e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NPY2R—epilepsy syndrome	8.85e-06	6.26e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—ADRA2A—epilepsy syndrome	8.84e-06	6.25e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GRM4—epilepsy syndrome	8.68e-06	6.14e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GRM3—epilepsy syndrome	8.68e-06	6.14e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SSTR2—epilepsy syndrome	8.52e-06	6.02e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—DUSP4—epilepsy syndrome	8.52e-06	6.02e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	8.51e-06	6.02e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—BDKRB2—epilepsy syndrome	8.5e-06	6.01e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CXCL12—epilepsy syndrome	8.5e-06	6.01e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ADRA2A—epilepsy syndrome	8.49e-06	6.01e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—BCHE—epilepsy syndrome	8.46e-06	5.98e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CNR1—epilepsy syndrome	8.34e-06	5.9e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PLCB1—epilepsy syndrome	8.31e-06	5.88e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GRM8—epilepsy syndrome	8.23e-06	5.82e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PGF—epilepsy syndrome	8.23e-06	5.82e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CCR2—epilepsy syndrome	8.21e-06	5.8e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—SST—epilepsy syndrome	8.21e-06	5.8e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—HTR7—epilepsy syndrome	8.14e-06	5.75e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—SLC2A1—epilepsy syndrome	8.07e-06	5.7e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—POMC—epilepsy syndrome	8.05e-06	5.7e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—ADRA2A—epilepsy syndrome	8.03e-06	5.68e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PLCB1—epilepsy syndrome	7.98e-06	5.64e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—TH—epilepsy syndrome	7.95e-06	5.62e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—CCL2—epilepsy syndrome	7.88e-06	5.57e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—OPRD1—epilepsy syndrome	7.85e-06	5.55e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GNAO1—epilepsy syndrome	7.85e-06	5.55e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.83e-06	5.54e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—AKT3—epilepsy syndrome	7.75e-06	5.48e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CXCL12—epilepsy syndrome	7.72e-06	5.46e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—BDKRB2—epilepsy syndrome	7.72e-06	5.46e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CNR1—epilepsy syndrome	7.57e-06	5.36e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PLCB1—epilepsy syndrome	7.55e-06	5.34e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GRM1—epilepsy syndrome	7.52e-06	5.32e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCR7—epilepsy syndrome	7.52e-06	5.32e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CHRM1—epilepsy syndrome	7.52e-06	5.32e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PDYN—epilepsy syndrome	7.52e-06	5.32e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ABCG2—epilepsy syndrome	7.45e-06	5.27e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—HTR7—epilepsy syndrome	7.39e-06	5.23e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP2C19—epilepsy syndrome	7.26e-06	5.14e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP11A1—epilepsy syndrome	7.22e-06	5.11e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—HBEGF—epilepsy syndrome	7.17e-06	5.07e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CDC42—epilepsy syndrome	7.07e-06	5e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GFAP—epilepsy syndrome	7.07e-06	5e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GAL—epilepsy syndrome	7.07e-06	5e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—AKT3—epilepsy syndrome	7.04e-06	4.98e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GRM5—epilepsy syndrome	6.99e-06	4.95e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CHRM3—epilepsy syndrome	6.99e-06	4.95e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CASP2—epilepsy syndrome	6.99e-06	4.95e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—AVP—epilepsy syndrome	6.85e-06	4.84e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CX3CR1—epilepsy syndrome	6.71e-06	4.74e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—HMOX1—epilepsy syndrome	6.64e-06	4.69e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—BDKRB1—epilepsy syndrome	6.58e-06	4.65e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CX3CL1—epilepsy syndrome	6.58e-06	4.65e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CAT—epilepsy syndrome	6.55e-06	4.63e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP2D6—epilepsy syndrome	6.52e-06	4.61e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CDC42—epilepsy syndrome	6.42e-06	4.54e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GABBR1—epilepsy syndrome	6.4e-06	4.52e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ABCB1—epilepsy syndrome	6.37e-06	4.5e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—AVP—epilepsy syndrome	6.22e-06	4.4e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	6.21e-06	4.39e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ADRA2A—epilepsy syndrome	6.2e-06	4.39e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—BCHE—epilepsy syndrome	6.18e-06	4.37e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HRH3—epilepsy syndrome	6.13e-06	4.34e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—OPRM1—epilepsy syndrome	6.04e-06	4.27e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GPX1—epilepsy syndrome	5.92e-06	4.19e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SLC2A1—epilepsy syndrome	5.89e-06	4.17e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PLCB1—epilepsy syndrome	5.83e-06	4.12e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CCR5—epilepsy syndrome	5.82e-06	4.12e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—TH—epilepsy syndrome	5.81e-06	4.11e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCR3—epilepsy syndrome	5.7e-06	4.03e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—HTR2A—epilepsy syndrome	5.7e-06	4.03e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NPY—epilepsy syndrome	5.56e-06	3.93e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ATP2A2—epilepsy syndrome	5.56e-06	3.93e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—AGT—epilepsy syndrome	5.41e-06	3.82e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	5.36e-06	3.79e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	5.36e-06	3.79e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	5.36e-06	3.79e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	5.36e-06	3.79e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	5.36e-06	3.79e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	5.29e-06	3.74e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—AGT—epilepsy syndrome	5.19e-06	3.67e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	5.18e-06	3.66e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—APOE—epilepsy syndrome	5.09e-06	3.6e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	5e-06	3.53e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	4.98e-06	3.52e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	4.98e-06	3.52e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	4.91e-06	3.47e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	4.85e-06	3.43e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	4.85e-06	3.43e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SST—epilepsy syndrome	4.85e-06	3.43e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—HMOX1—epilepsy syndrome	4.85e-06	3.43e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	4.81e-06	3.4e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CAT—epilepsy syndrome	4.78e-06	3.38e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	4.74e-06	3.35e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	4.72e-06	3.34e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ABCB1—epilepsy syndrome	4.65e-06	3.29e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	4.56e-06	3.22e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	4.56e-06	3.22e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	4.55e-06	3.22e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	4.54e-06	3.21e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	4.52e-06	3.2e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	4.47e-06	3.16e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	4.47e-06	3.16e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	4.46e-06	3.15e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—POMC—epilepsy syndrome	4.37e-06	3.09e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	4.37e-06	3.09e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GPX1—epilepsy syndrome	4.32e-06	3.06e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	4.24e-06	3e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	4.16e-06	2.94e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	4.13e-06	2.92e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	4.06e-06	2.87e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	4.04e-06	2.86e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ALB—epilepsy syndrome	3.98e-06	2.82e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	3.84e-06	2.72e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	3.8e-06	2.69e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	3.8e-06	2.68e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—AGT—epilepsy syndrome	3.79e-06	2.68e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—APOE—epilepsy syndrome	3.72e-06	2.63e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	3.67e-06	2.6e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PTGS2—epilepsy syndrome	3.49e-06	2.47e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	3.47e-06	2.46e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	3.38e-06	2.39e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	3.37e-06	2.38e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	3.36e-06	2.38e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	3.25e-06	2.3e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	3.21e-06	2.27e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—POMC—epilepsy syndrome	3.19e-06	2.26e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	3.12e-06	2.21e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	3.06e-06	2.16e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ALB—epilepsy syndrome	2.91e-06	2.06e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	2.9e-06	2.05e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	2.9e-06	2.05e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	2.84e-06	2.01e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	2.78e-06	1.97e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	2.68e-06	1.9e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	2.67e-06	1.89e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PTGS2—epilepsy syndrome	2.55e-06	1.8e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	2.44e-06	1.73e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	2.39e-06	1.69e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	2.16e-06	1.53e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	2e-06	1.42e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	1.97e-06	1.39e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.82e-06	1.29e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	1.81e-06	1.28e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	1.76e-06	1.24e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—AKT1—epilepsy syndrome	1.75e-06	1.24e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	1.71e-06	1.21e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	1.66e-06	1.17e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	1.58e-06	1.11e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	1.53e-06	1.08e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—AKT1—epilepsy syndrome	1.28e-06	9.05e-06	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	9.79e-07	6.92e-06	CbGpPWpGaD
